Project
Pharmacology, pharmacogenomics, drug discovery and design, drug therapy [116]
Project
BURULI Path: the subversive role of mycolactone
Caroline Demangel • Laure Guenin-Mace
Project
Inhibitors of the 2’-deoxyribonucleotide N-hydrolase DNPH1, an enzyme involved in cellular growth and angiogenesis
Sylvie Pochet • Pierre Alexandr Kaminski
Project
Antibiotic resistances and drug screening
Brigitte Gicquel
Project
Nanotherapeutics for Antibiotic Resistant Emerging Bacterial pathogens
Brigitte Gicquel
Project
Cyanobacterial bioactive compounds
Muriel Gugger
Project
Innate immune response to C. trachomatis infection in the female genital tract
Yongzheng Wu
Tool
Optogenetic
Laboratory
Molecular Mechanisms of Pathological and Physiological Ageing
Miria Ricchetti
Group
Group: Biochemistry and chemobiology
Hélène Munier-Lehmann
Group
Group: Dynamics & Drug Design
Arnaud Blondel
Group
Structural biology of metabolic enzymes and complexes
Marco Bellinzoni
Group
Biology of Malaria targets and Antimalarials
Jean-Christophe Barale
Program Project
LabEx IBEID – Integrative Biology of Emerging Infectious Diseases
Presentation The aim of the Integrative Biology of Emerging Infectious Diseases (IBEID) project, coordinated by Professors Philippe Sansonetti and Pascale Cossart and currently coordinated by Carla Saleh and Philippe Bastin, is to develop a […]
2015
Publication
Original 2-(3-Alkoxy-1H-pyrazol-1-yl)azines Inhibitors of Human Dihydroorotate Dehydrogenase (DHODH)
Journal of medicinal chemistry
Lucas-Hourani M, Munier-Lehmann H, El Mazouni F, Malmquist NA, Harpon J, Coutant EP, Guillou S, Helynck O, Noel A, Scherf A, Phillips MA, Tangy F, Vidalain PO, Janin YL
Platform